Frequency of variants in Mendelian Alzheimer's disease genes within the Alzheimer's Disease Sequencing Project
Journal of Alzheimer’s Disease · 2025-04 · 104 (3) · 841-851
DOI: 10.1177/13872877251320375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 14.03.2025. Verfasst von Dongyu Wang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Presenilin-2, Presenilin-1, Amyloid beta-Protein Precursor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIA.
Themen: Demenz
Abstract (Originalsprache)
Background
Prior studies examined variants within presenilin-2 ( PSEN2 ), presenilin-1 ( PSEN1 ), and amyloid precursor protein ( APP ) genes. However, previously-reported clinically-relevant variants and other predicted damaging missense (DM) variants have not been characterized in a newer release of the Alzheimer's Disease Sequencing Project (ADSP).
Objective
To characterize previously-reported clinically-relevant variants and DM variants in PSEN2, PSEN1, APP within the participants from the ADSP.
Methods
We identified rare variants (MAF < 1%) in PSEN2 , PSEN1, and APP in 14,641 individuals with whole genome sequencing and 16,849 individuals with whole exome sequencing available (N total = 31,490). We additionally curated variants from ClinVar, OMIM, and Alzforum and report carriers of variants in clinical databases as well as predicted DM variants in these genes.
Results
We detected 31 previously-reported clinically-relevant variants with alternate alleles observed within the ADSP: 4 variants in PSEN2 , 25 in PSEN1 , and 2 in APP . The overall variant carrier rate for the 31 clinically-relevant variants in the ADSP was 0.3%. We observed that 79.5% of the variant carriers were cases compared to 3.9% were controls. In those with AD, the mean age of onset of AD among carriers of these clinically-relevant variants was 19.6 ± 1.4 years earlier compared with noncarriers (p = 7.8 × 10 −57 ). Additionally, we identified 197 rare variants (MAF < 1%) within ADSP participants not reported in known clinical databases.
Conclusions
A small proportion of individuals in the ADSP are carriers of a previously-reported clinically-relevant variant allele for AD and these participants have significantly earlier age of AD onset compared to noncarriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
- Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
- Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
- NHLBI Framingham Heart Study, Framingham, MA, USA.
- Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USA.
- Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, MO, USA.
ORCID-Profile: Dongyu Wang, Alexandra Scalici, Yanbing Wang, Honghuang Lin, Achilleas Pitsillides, Nancy Heard-Costa, Carlos Cruchaga, Ellen Ziegemeier, Joshua C Bis, Eric Boerwinkle, Josée Dupuis, Sudha Seshadri, Alison M Goate, Anita L DeStefano, Gina M Peloso
Förderung
- NIA NIH HHS
- NIA
Zitieren
APA
Wang, D., Scalici, A., Wang, Y., Lin, H., Pitsillides, A., Heard-Costa, N., Cruchaga, C., Ziegemeier, E., Bis, J. C., Fornage, M., Boerwinkle, E., De Jager, P. L., Wijsman, E., Dupuis, J., Renton, A. E., Seshadri, S., Goate, A. M., Alzheimer's Disease Neuroimaging Initiative (ADNI), The Alzheimer's Disease Sequencing Project, DeStefano, A. L., & Peloso, G. M. (2025). Frequency of variants in Mendelian Alzheimer's disease genes within the Alzheimer's Disease Sequencing Project. Journal of Alzheimer’s Disease, 104(3), 841-851. https://doi.org/10.1177/13872877251320375
Vancouver
Wang D, Scalici A, Wang Y, Lin H, Pitsillides A, Heard-Costa N, et al. Frequency of variants in Mendelian Alzheimer's disease genes within the Alzheimer's Disease Sequencing Project. Journal of Alzheimer’s Disease. 2025;104(3):841-851. doi:10.1177/13872877251320375
BibTeX
@article{Wang2025,
author = {Wang, Dongyu and Scalici, Alexandra and Wang, Yanbing and Lin, Honghuang and Pitsillides, Achilleas and Heard-Costa, Nancy and Cruchaga, Carlos and Ziegemeier, Ellen and Bis, Joshua C and Fornage, Myriam and Boerwinkle, Eric and De Jager, Philip L and Wijsman, Ellen and Dupuis, Josée and Renton, Alan E and Seshadri, Sudha and Goate, Alison M and Alzheimer's Disease Neuroimaging Initiative (ADNI), The Alzheimer's Disease Sequencing Project, Alzheimer's Disease Neuroimaging Initiative (ADNI), The Alzheimer's Disease Sequencing Project and DeStefano, Anita L and Peloso, Gina M},
title = {Frequency of variants in Mendelian Alzheimer's disease genes within the Alzheimer's Disease Sequencing Project},
journal = {Journal of Alzheimer’s Disease},
year = {2025},
volume = {104},
number = {3},
pages = {841--851},
doi = {10.1177/13872877251320375}
}
EUVIMED